Living with PAWS-GIST
PAWS-GIST is an initiative of GIST Support UK with the aim of providing support and advice to patients suffering from a very rare form of GIST cancer. Wild-type GIST affects about 10% of GIST patients and there is currently no cure or universally effective treatment. 'PAWS' is an acronym that includes some of the general sub-groups that make up Wild-type GIST IE paediatric, adolescent and syndromic.
- Dr Ramesh Bulusu Consultant Clinical Oncologist, Addenbrookes Hospital, Cambridge
- Dr Ian Geh Consultant - Clinical Oncologist, Queen Elizabeth Hospital, Birmingham
- Prof Bass Hassan - Professor of Medical Oncology, University of Oxford
- Prof Ian Judson - Professor of Cancer Pharmacology, The Royal Marsden, London
- Dr Robin Jones - Consultant Oncologist, The Royal Marsden, London.
- Dr Charlotte Benson - Consultant Oncologist, The Roya Marsden, London.
- Dr Mike Leahy - Consultant Medical Oncologist, Christie Hospital, Manchester
- Dr Beatrice Seddon - Consultant Clinical Oncologist, University College Hospital, London
- Dr Palma Dileo - Consultant Oncologist, University College Hospital, London
- Dr Mark Verrill - Consultant Medical Oncologist, Northern Centre for Cancer Care, Newcastle
Further: Read about the Team.
Request Mutational Testing
Ideally, mutational analysis will form part of the process of initial diagnosis for all GIST patients. It will identify specific mutations within the tumour that will inform treatment paths and prognosis. If no mutations in KIT / PGDRFA are found it will confirm Wild-type status. Further testing for Wild-type patients is necessary to identify specific sub-types that in turn inform treatment / prognosis and identify any (relatively small) risk of an inherited condition.
Access to primary clinical samples (tumour and matched normal blood) is vital to progress our understanding of rare tumours such as GIST. With your help we can set up a national collection of samples available to anyone with a good quality research proposal.
- This bank is a valuable resource that will support GIST cancer research locally, nationally and internationally.
- It will provide researchers with a diverse selection of high quality GIST tumour specimens and clinical data obtained by dedicated tumour bank staff who follow strict procedures and ethical guidelines.
- Research will progress faster if there is a good supply of GIST tissue upon which to test potential treatments and develop new diagnostic tests.
Operating within the NICR in Newcastle, the GIST Tumour Bank will coordinate the collection, storage and distribution of a variety of paediatric and adult biospecimens including fresh, frozen and paraffin blocks in addition to blood samples and clinical data.
Working in collaboration with pathologists, medical oncologists, surgeons and other hospital personnel, specially trained staff will obtain patient consent, collect samples and assemble clinical information about each donor and their corresponding specimens.
Please try to assist in this research by sending samples to the National GIST biobank (see 'Tumour Bank Flyer' link below).
If you have samples to donate please contact:
Professor Andy Hall for details of the consent and donation process.
Further: National GIST Tumour Bank Flyer (Pdf, 345K)